Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04512248 · ClinicalTrials.gov registry record · NA

Integrating the Quit and Stay Quit Monday Model Into Smoking Cessation Services for Smokers With Mental Health Conditions

A NA study of Smoking Cessation, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT04512248 is a NA study of Smoking Cessation that has completed, run by NYU Langone Health. The registered enrollment target is 70 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04512248, a NA study of Smoking Cessation, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The Quit and Stay Quit Monday model is an innovative smoking cessation approach that guides smokers' behavior without requiring additional resources. The investigator will conduct a randomized control trial evaluating the effectiveness of this model as compared to usual smoking cessation care in a population of smokers with a mental health condition.

Conditions Studied

Interventions

  • BEHAVIORAL Quit and Stay Quit Monday Model

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2020-10-01
Est. Completion 2021-10-30
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT04512248

The ClinicalTrials.gov registry entry for NCT04512248 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (85% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 1 intervention - of which Quit and Stay Quit Monday Model is the first listed.

NCT04512248 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04512248 about?

NCT04512248 is a clinical study titled "Integrating the Quit and Stay Quit Monday Model Into Smoking Cessation Services for Smokers With Mental Health Conditions". The Quit and Stay Quit Monday model is an innovative smoking cessation approach that guides smokers' behavior without requiring additional resources. The investigator will conduct a randomized control trial evaluating the effectiveness of this model as compared to usual smoking cessation care in a p...

What is the current status of trial NCT04512248?

This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2020-10-01. Estimated completion is 2021-10-30.

What conditions does trial NCT04512248 study?

This clinical trial studies the following conditions: Smoking Cessation.

What interventions are being tested in trial NCT04512248?

The interventions under investigation include: Quit and Stay Quit Monday Model (BEHAVIORAL).

Who is sponsoring clinical trial NCT04512248?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04512248 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.